Healthcare startup Otter Health launched with $8 million in seed funding co-led by Fika Ventures and Evidenced Capital. Slow Ventures, Metrodora, CoFound Partners, Patient Capital, Semper Virens and Layout Ventures also invested. The company says its AI-powered platform helps health plans, health systems and risk-bearing provider groups manage care quality and spending without relying on prior authorization, the process requiring clinicians to obtain payer approval before some care.

Otter compares clinical decisions with evidence-based standards in real time across referrals, outpatient procedures, care transitions and other decisions. It identifies variation and supports clinician engagement so payers and providers can review care against shared quality goals. The company says its approach aims to reduce unnecessary spending while preserving visibility and accountability. Funding will help it expand into more clinical specialties and healthcare organizations, improve its ability to identify spending and quality opportunities, and hire engineers and physicians.

Otter’s executives say its initial work with healthcare organizations removed prior authorization in certain areas while keeping non-concordant clinical decisions below 5%. They also report savings on low-value care outside the authorization process. The company estimates roughly 60% of low-value healthcare spending occurs beyond traditional authorization controls, amounting to millions of dollars in avoidable annual spending per 1,000 people covered. An American Medical Association survey cited in the report found physicians complete nearly 40 prior authorizations per week; 93% said authorization delays necessary care, and 82% said it can lead patients to abandon treatment.

Co-founder Keith Florance said faster automated authorization does not resolve the adversarial workflow between payers and providers. Otter instead uses real clinical data and clinician engagement to guide care toward evidence-based standards, while giving payers a view of whether decisions align with those standards. The founding team includes healthcare strategy leaders and clinicians Amol Navathe, M.D., Ph.D., Keith Florance, Ram Keralapura and Will Bartlett. Florance previously spent two decades working on value-based care and payment models, co-founded Embedded Health with Navathe and Zeke Emanuel, and sold it to Clarify Health Solutions in 2022. Otter enters a market where federal rules and state laws are pushing health plans to drop prior authorization for routine services, while plans still need ways to monitor care quality and cost.

Healthcare startup Otter Health launched with $8 million in seed funding co-led by Fika Ventures and Evidenced Capital. Slow Ventures, Metrodora, CoFound Partners, Patient Capital, Semper Virens and Layout Ventures also invested. The company says its AI-powered platform helps health plans, health systems and risk-bearing provider groups manage care quality and spending without relying on prior authorization, the process requiring clinicians to obtain payer approval before some care.

Otter compares clinical decisions with evidence-based standards in real time across referrals, outpatient procedures, care transitions and other decisions. It identifies variation and supports clinician engagement so payers and providers can review care against shared quality goals. The company says its approach aims to reduce unnecessary spending while preserving visibility and accountability. Funding will help it expand into more clinical specialties and healthcare organizations, improve its ability to identify spending and quality opportunities, and hire engineers and physicians.

Otter’s executives say its initial work with healthcare organizations removed prior authorization in certain areas while keeping non-concordant clinical decisions below 5%. They also report savings on low-value care outside the authorization process. The company estimates roughly 60% of low-value healthcare spending occurs beyond traditional authorization controls, amounting to millions of dollars in avoidable annual spending per 1,000 people covered. An American Medical Association survey cited in the report found physicians complete nearly 40 prior authorizations per week; 93% said authorization delays necessary care, and 82% said it can lead patients to abandon treatment.

Co-founder Keith Florance said faster automated authorization does not resolve the adversarial workflow between payers and providers. Otter instead uses real clinical data and clinician engagement to guide care toward evidence-based standards, while giving payers a view of whether decisions align with those standards. The founding team includes healthcare strategy leaders and clinicians Amol Navathe, M.D., Ph.D., Keith Florance, Ram Keralapura and Will Bartlett. Florance previously spent two decades working on value-based care and payment models, co-founded Embedded Health with Navathe and Zeke Emanuel, and sold it to Clarify Health Solutions in 2022. Otter enters a market where federal rules and state laws are pushing health plans to drop prior authorization for routine services, while plans still need ways to monitor care quality and cost.